227 related articles for article (PubMed ID: 21722370)
1. Survival advantages conferred to colon cancer cells by E-selectin-induced activation of the PI3K-NFκB survival axis downstream of Death receptor-3.
Porquet N; Poirier A; Houle F; Pin AL; Gout S; Tremblay PL; Paquet ER; Klinck R; Auger FA; Huot J
BMC Cancer; 2011 Jul; 11():285. PubMed ID: 21722370
[TBL] [Abstract][Full Text] [Related]
2. Death receptor-3, a new E-Selectin counter-receptor that confers migration and survival advantages to colon carcinoma cells by triggering p38 and ERK MAPK activation.
Gout S; Morin C; Houle F; Huot J
Cancer Res; 2006 Sep; 66(18):9117-24. PubMed ID: 16982754
[TBL] [Abstract][Full Text] [Related]
3. Id-1 activation of PI3K/Akt/NFkappaB signaling pathway and its significance in promoting survival of esophageal cancer cells.
Li B; Cheung PY; Wang X; Tsao SW; Ling MT; Wong YC; Cheung AL
Carcinogenesis; 2007 Nov; 28(11):2313-20. PubMed ID: 17638919
[TBL] [Abstract][Full Text] [Related]
4. RNA interference of PARG could inhibit the metastatic potency of colon carcinoma cells via PI3-kinase/Akt pathway.
Li Q; Li M; Wang YL; Fauzee NJ; Yang Y; Pan J; Yang L; Lazar A
Cell Physiol Biochem; 2012; 29(3-4):361-72. PubMed ID: 22508044
[TBL] [Abstract][Full Text] [Related]
5. p38 and JNK pathways control E-selectin-dependent extravasation of colon cancer cells by modulating miR-31 transcription.
Zhong L; Simoneau B; Huot J; Simard MJ
Oncotarget; 2017 Jan; 8(1):1678-1687. PubMed ID: 27926494
[TBL] [Abstract][Full Text] [Related]
6. A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFkappaB in human endothelial cells.
Madge LA; Pober JS
J Biol Chem; 2000 May; 275(20):15458-65. PubMed ID: 10748004
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor stimulates nuclear factor-κB activation and heme oxygenase-1 expression via c-Src, NADPH oxidase, PI3K, and Akt in human colon cancer cells.
Lien GS; Wu MS; Bien MY; Chen CH; Lin CH; Chen BC
PLoS One; 2014; 9(8):e104891. PubMed ID: 25122478
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor-dependent, NF-kappaB-independent activation of the phosphatidylinositol 3-kinase/Akt pathway inhibits ultraviolet irradiation-induced caspases-3, -8, and -9 in human keratinocytes.
Wang HQ; Quan T; He T; Franke TF; Voorhees JJ; Fisher GJ
J Biol Chem; 2003 Nov; 278(46):45737-45. PubMed ID: 12952968
[TBL] [Abstract][Full Text] [Related]
9. Poly(I:C)-induced adhesion molecule expression mediated by NF-{kappa}B and phosphoinositide 3-kinase-Akt signaling pathways in human corneal fibroblasts.
Orita T; Kimura K; Zhou HY; Nishida T
Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):5556-60. PubMed ID: 20574012
[TBL] [Abstract][Full Text] [Related]
10. Regulation of transendothelial migration of colon cancer cells by E-selectin-mediated activation of p38 and ERK MAP kinases.
Tremblay PL; Auger FA; Huot J
Oncogene; 2006 Oct; 25(50):6563-73. PubMed ID: 16715142
[TBL] [Abstract][Full Text] [Related]
11. Src activation regulates anoikis in human colon tumor cell lines.
Windham TC; Parikh NU; Siwak DR; Summy JM; McConkey DJ; Kraker AJ; Gallick GE
Oncogene; 2002 Nov; 21(51):7797-807. PubMed ID: 12420216
[TBL] [Abstract][Full Text] [Related]
12. Sulfatase 2 protects hepatocellular carcinoma cells against apoptosis induced by the PI3K inhibitor LY294002 and ERK and JNK kinase inhibitors.
Lai JP; Sandhu DS; Yu C; Moser CD; Hu C; Shire AM; Aderca I; Murphy LM; Adjei AA; Sanderson S; Roberts LR
Liver Int; 2010 Nov; 30(10):1522-8. PubMed ID: 21040406
[TBL] [Abstract][Full Text] [Related]
13. Co-Expression and Functional Interactions of Death Receptor 3 and E-Selectin in Clear Cell Renal Cell Carcinoma.
Al-Lamki RS; Wang J; Pober JS; Bradley JR
Am J Pathol; 2022 Apr; 192(4):722-736. PubMed ID: 35063404
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinib mesylate or chemotherapy.
Tsurutani J; West KA; Sayyah J; Gills JJ; Dennis PA
Cancer Res; 2005 Sep; 65(18):8423-32. PubMed ID: 16166321
[TBL] [Abstract][Full Text] [Related]
15. Apoptotic phenotype alters the capacity of tumor necrosis factor-related apoptosis-inducing ligand to induce human vascular endothelial activation.
Chen PL; Easton A
J Vasc Res; 2008; 45(2):111-22. PubMed ID: 17940338
[TBL] [Abstract][Full Text] [Related]
16. LY294002 enhances boswellic acid-induced apoptosis in colon cancer cells.
Liu JJ; Duan RD
Anticancer Res; 2009 Aug; 29(8):2987-91. PubMed ID: 19661305
[TBL] [Abstract][Full Text] [Related]
17. WITHDRAWN: Restoration of transforming growth factor-beta receptor II expression in colon cancer cells with microsatellite instability increases metastatic potential in vivo.
Liu XQ; Rajput A; Geng L; Ongchin M; Chaudhuri A; Wang J
J Biol Chem; 2011 May; 286(18):16082-90. PubMed ID: 21454688
[TBL] [Abstract][Full Text] [Related]
18. The PI3-kinase-Akt pathway promotes mesangial cell survival and inhibits apoptosis in vitro via NF-kappa B and Bad.
Shimamura H; Terada Y; Okado T; Tanaka H; Inoshita S; Sasaki S
J Am Soc Nephrol; 2003 Jun; 14(6):1427-34. PubMed ID: 12761242
[TBL] [Abstract][Full Text] [Related]
19. p38 activation induces production of miR-146a and miR-31 to repress E-selectin expression and inhibit transendothelial migration of colon cancer cells.
Zhong L; Huot J; Simard MJ
Sci Rep; 2018 Feb; 8(1):2334. PubMed ID: 29402939
[TBL] [Abstract][Full Text] [Related]
20. Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression.
Bharadwaj U; Marin-Muller C; Li M; Chen C; Yao Q
Mol Cancer; 2011 Aug; 10():106. PubMed ID: 21880146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
